D
Cellectis S.A.
CLLS
$2.99
$0.000.00%
D
Sell
11/3/2023Upgraded
Cellectis S.A. (CLLS) was upgraded to D- from E+ on 11/3/2023 due to an increase in the growth index and volatility index.
Cellectis S.A. (CLLS) was upgraded to D- from E+ on 11/3/2023 due to an increase in the growth index and volatility index.
E
Sell
9/20/2023Downgrade
Cellectis S.A. (CLLS) was downgraded to E+ from D- on 9/20/2023 due to a decline in the total return index and volatility index.
Cellectis S.A. (CLLS) was downgraded to E+ from D- on 9/20/2023 due to a decline in the total return index and volatility index.
D
Sell
8/30/2023Upgraded
Cellectis S.A. (CLLS) was upgraded to D- from E+ on 8/30/2023 due to an increase in the total return index and volatility index.
Cellectis S.A. (CLLS) was upgraded to D- from E+ on 8/30/2023 due to an increase in the total return index and volatility index.
E
Sell
4/28/2023Downgrade
Cellectis S.A. (CLLS) was downgraded to E+ from D- on 4/28/2023 due to a decline in the total return index and volatility index.
Cellectis S.A. (CLLS) was downgraded to E+ from D- on 4/28/2023 due to a decline in the total return index and volatility index.
D
Sell
4/13/2023Upgraded
Cellectis S.A. (CLLS) was upgraded to D- from E+ on 4/13/2023 due to a large increase in the growth index and volatility index. Total revenue increased 801.72% from $1.92M to $17.32M, EBIT increased 82.93% from -$33.16M to -$5.66M, and earnings per share increased from -$0.63 to -$0.59.
Cellectis S.A. (CLLS) was upgraded to D- from E+ on 4/13/2023 due to a large increase in the growth index and volatility index. Total revenue increased 801.72% from $1.92M to $17.32M, EBIT increased 82.93% from -$33.16M to -$5.66M, and earnings per share increased from -$0.63 to -$0.59.
E
Sell
3/14/2023Downgrade
Cellectis S.A. (CLLS) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
Cellectis S.A. (CLLS) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
D
Sell
2/27/2023Downgrade
Cellectis S.A. (CLLS) was downgraded to D- from D on 2/27/2023 due to a decline in the total return index.
Cellectis S.A. (CLLS) was downgraded to D- from D on 2/27/2023 due to a decline in the total return index.
D
Sell
2/9/2023Upgraded
Cellectis S.A. (CLLS) was upgraded to D from E+ on 02/09/2023.
Cellectis S.A. (CLLS) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Cellectis S.A. (CLLS) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index.
Cellectis S.A. (CLLS) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index.
D
Sell
2/2/2023Upgraded
Cellectis S.A. (CLLS) was upgraded to D from D- on 2/2/2023 due to an increase in the total return index and volatility index.
Cellectis S.A. (CLLS) was upgraded to D from D- on 2/2/2023 due to an increase in the total return index and volatility index.
D
Sell
11/7/2022Downgrade
Cellectis S.A. (CLLS) was downgraded to D- from D on 11/7/2022 due to a decline in the growth index and solvency index. Earnings per share declined from -$0.42 to -$0.63, total revenue declined 30.5% from $2.76M to $1.92M, and debt to equity increased from 0.16 to 0.19.
Cellectis S.A. (CLLS) was downgraded to D- from D on 11/7/2022 due to a decline in the growth index and solvency index. Earnings per share declined from -$0.42 to -$0.63, total revenue declined 30.5% from $2.76M to $1.92M, and debt to equity increased from 0.16 to 0.19.
D
Sell
8/8/2022Upgraded
Cellectis S.A. (CLLS) was upgraded to D from D- on 8/8/2022 due to a large increase in the growth index. Earnings per share increased from -$0.7015 to -$0.42, operating cash flow increased 35.62% from -$36.61M to -$23.57M, and EBIT increased 3.32% from -$35.25M to -$34.08M.
Cellectis S.A. (CLLS) was upgraded to D from D- on 8/8/2022 due to a large increase in the growth index. Earnings per share increased from -$0.7015 to -$0.42, operating cash flow increased 35.62% from -$36.61M to -$23.57M, and EBIT increased 3.32% from -$35.25M to -$34.08M.
D
Sell
5/18/2022Downgrade
Cellectis S.A. (CLLS) was downgraded to D- from D on 5/18/2022 due to a large decline in the growth index and solvency index. Operating cash flow declined 73.66% from -$21.08M to -$36.61M, total revenue declined 71.95% from $13.66M to $3.83M, and earnings per share declined from -$0.5517 to -$0.7015.
Cellectis S.A. (CLLS) was downgraded to D- from D on 5/18/2022 due to a large decline in the growth index and solvency index. Operating cash flow declined 73.66% from -$21.08M to -$36.61M, total revenue declined 71.95% from $13.66M to $3.83M, and earnings per share declined from -$0.5517 to -$0.7015.
D
Sell
5/16/2022Upgraded
Cellectis S.A. (CLLS) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
Cellectis S.A. (CLLS) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Cellectis S.A. (CLLS) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
Cellectis S.A. (CLLS) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
Cellectis S.A. (CLLS) was upgraded to D from E+ on 05/04/2022.
Cellectis S.A. (CLLS) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Cellectis S.A. (CLLS) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
Cellectis S.A. (CLLS) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
D
Sell
4/21/2022Upgraded
Cellectis S.A. (CLLS) was upgraded to D from E+ on 04/21/2022.
Cellectis S.A. (CLLS) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Cellectis S.A. (CLLS) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.12 to 0.13, and the quick ratio declined from 4.45 to 4.39.
Cellectis S.A. (CLLS) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.12 to 0.13, and the quick ratio declined from 4.45 to 4.39.
D
Sell
11/10/2021Upgraded
Cellectis S.A. (CLLS) was upgraded to D from D- on 11/10/2021 due to an increase in the growth index. Earnings per share increased from -$0.88 to -$0.8228.
Cellectis S.A. (CLLS) was upgraded to D from D- on 11/10/2021 due to an increase in the growth index. Earnings per share increased from -$0.88 to -$0.8228.
D
Sell
11/8/2021Downgrade
Cellectis S.A. (CLLS) was downgraded to D- from D on 11/8/2021 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.28 to -$0.88, EBIT declined 88.28% from -$19.91M to -$37.48M, and total revenue declined 47.74% from $27.97M to $14.62M.
Cellectis S.A. (CLLS) was downgraded to D- from D on 11/8/2021 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.28 to -$0.88, EBIT declined 88.28% from -$19.91M to -$37.48M, and total revenue declined 47.74% from $27.97M to $14.62M.
D
Sell
5/3/2021Downgrade
Cellectis S.A. (CLLS) was downgraded to D from D+ on 5/3/2021 due to a noticeable decline in the growth index and volatility index. Operating cash flow declined 32.33% from -$25.61M to -$33.89M, earnings per share declined from -$0.7131 to -$0.9288, and EBIT declined 29.36% from -$29.36M to -$37.98M.
Cellectis S.A. (CLLS) was downgraded to D from D+ on 5/3/2021 due to a noticeable decline in the growth index and volatility index. Operating cash flow declined 32.33% from -$25.61M to -$33.89M, earnings per share declined from -$0.7131 to -$0.9288, and EBIT declined 29.36% from -$29.36M to -$37.98M.
D
Sell
2/26/2021Upgraded
Cellectis S.A. (CLLS) was upgraded to D+ from D on 2/26/2021 due to an increase in the total return index, volatility index and valuation index.
Cellectis S.A. (CLLS) was upgraded to D+ from D on 2/26/2021 due to an increase in the total return index, volatility index and valuation index.
D
Sell
12/3/2020Downgrade
Cellectis S.A. (CLLS) was downgraded to D from D+ on 12/3/2020 due to a decline in the valuation index and solvency index.
Cellectis S.A. (CLLS) was downgraded to D from D+ on 12/3/2020 due to a decline in the valuation index and solvency index.
D
Sell
11/18/2020Upgraded
Cellectis S.A. (CLLS) was upgraded to D+ from D on 11/18/2020 due to a substantial increase in the growth index, total return index and valuation index. Total revenue increased 100.22% from $4.62M to $9.24M, EBIT increased 11.13% from -$33.03M to -$29.36M, and earnings per share increased from -$0.76 to -$0.71.
Cellectis S.A. (CLLS) was upgraded to D+ from D on 11/18/2020 due to a substantial increase in the growth index, total return index and valuation index. Total revenue increased 100.22% from $4.62M to $9.24M, EBIT increased 11.13% from -$33.03M to -$29.36M, and earnings per share increased from -$0.76 to -$0.71.
D
Sell
9/18/2020None
Cellectis S.A. (CLLS) was downgraded to D from U on 09/18/2020.
Cellectis S.A. (CLLS) was downgraded to D from U on 09/18/2020.
NASDAQ
05/03/2024 4:00PM Eastern
Quotes delayed
